Effect of intravitreal anti-vascular endothelial growth factor therapy on the risk of arterial thromboembolic events: a meta-analysis.

QR Code

Effect of intravitreal anti-vascular endothelial growth factor therapy on the risk of arterial thromboembolic events: a meta-analysis.

<h4>Background</h4>Intravitreal anti-vascular endothelial growth factor (VEGF) monoclonal antibodies are used in ocular neovascular diseases. A consensus has emerged that intravenous anti-VEGF can increase the risk of arterial thromboembolic events. However, the role of intravitreal anti...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jin-Wei Cheng, Shi-Wei Cheng, Guo-Cai Lu, Rui-Li Wei
Format:	article
Langue:	EN
Publié:	Public Library of Science (PLoS) 2012
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/749e069a68cd41bc9da7ac69440e23a1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
par: Ruão M, et autres
Publié: (2017)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
par: Jihyun Yoon, et autres
Publié: (2021)

Incidence of outer retinal tubulation in eyes with choroidal neovascularization under intravitreal anti-vascular endothelial growth factor therapy in a Japanese population
par: Takagi S, et autres
Publié: (2017)

Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
par: Jihyun Yoon, et autres
Publié: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
par: Tan CS, et autres
Publié: (2017)

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
par: Bhatia D, et autres
Publié: (2021)

Evaluation of the Safety of Bilateral Same-Day Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents: Experience of a Large Korean Retina Center
par: Jang K, et autres
Publié: (2020)

Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries
par: Ghoraba HH, et autres
Publié: (2018)

Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.
par: Wei Wang, et autres
Publié: (2014)

Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy
par: Chu-Hsuan Huang, et autres
Publié: (2021)

Endothelialization of arterial vascular grafts by circulating monocytes
par: Randall J. Smith, et autres
Publié: (2020)

Effect of fish oil supplementation on fasting vascular endothelial function in humans: a meta-analysis of randomized controlled trials.
par: Wei Xin, et autres
Publié: (2012)

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
par: Cheema MR, et autres
Publié: (2021)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
par: Bhagat D, et autres
Publié: (2020)

Risk assessment of thromboembolic events in hospitalized cancer patients
par: Federico Nichetti, et autres
Publié: (2021)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
par: Jun JH, et autres
Publié: (2016)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
par: Kim M
Publié: (2016)

Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration
par: Kano M, et autres
Publié: (2015)

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials.
par: Kazem Rahimi, et autres
Publié: (2012)

Nephrotoxicity induced by vascular endothelial growth factor inhibitors
par: Shirinsadat Badri, et autres
Publié: (2022)

Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis
par: Masashi Nagao, et autres
Publié: (2017)

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
par: Wingard JB, et autres
Publié: (2019)

Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
par: Maria Totaro, et autres
Publié: (2021)

Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells
par: Qiong Xu, et autres
Publié: (2021)

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension
par: Olga Tura-Ceide, et autres
Publié: (2021)

Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension
par: Sarath Babu Nukala, et autres
Publié: (2021)

IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus.
par: Nadera J Sweiss, et autres
Publié: (2010)

Predictive Factors And Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment Of Retinal Angiomatous Proliferation
par: Maruyama-Inoue M, et autres
Publié: (2019)

Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
par: Nixon DR, et autres
Publié: (2021)

Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients
par: Abu-Yaghi NE, et autres
Publié: (2020)

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
par: Kiss S, et autres
Publié: (2014)

In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles
par: Hsieh WJ, et autres
Publié: (2012)

Expression of mRNA vascular endothelial growth factor in hypospadias patients
par: Prahara Yuri, et autres
Publié: (2021)

Vascular Endothelial Growth Factor in Unstimulated Saliva of the Patients with Minor Aphtha
par: S Seifi,, et autres
Publié: (2012)

Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients.
par: Christian Valentin Eisenring, et autres
Publié: (2013)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events after Total Knee Arthroplasty
par: Abiram Bala MD, et autres
Publié: (2021)

Endothelial progenitor cells and vascular endothelial growth factor after endovascular interventions in patients with type 2 diabetes
par: Marina Sergeevna Michurova, et autres
Publié: (2017)

Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity
par: Astrid Hubert, et autres
Publié: (2020)

Anti-metastatic effect of methylprednisolone targeting vascular endothelial cells under surgical stress
par: Takaomi Hagi, et autres
Publié: (2021)

Vascular Endothelial Growth Factor Expression in Correlation with Stage Juvenile Nasopharyngeal Angiofibroma
par: Ifiq Budiyan Nazar, et autres
Publié: (2021)